Recently, researchers at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), an autonomous institute under the Department of Science and Technology, have developed a new technology for early and accurate detection of HIV. The newly developed GQ Topology-Targeted Reliable Conformational Polymorphism (GQ-RCP) platform, adapted from SARS-CoV-2 diagnostics, highlights the innovative capabilities of Indian research institutions.
Key Features of GQ-RCP Platform
- GQ-RCP Platform: The G-Quadruplex (GQ) structure is a unique four-stranded DNA conformation that plays a crucial role in various biological processes, including gene regulation and genome stability.
- Functionality: This platform enables targeted detection of HIV-derived DNA structures using a fluorometric test, enhancing diagnostic reliability and significantly reducing false positives associated with HIV detection. The GQ-RCP platform promises to enhance early detection capabilities and reduce reliance on less specific general DNA sensing probes that contribute to diagnostic inaccuracies.
- Detection Process: The detection process involves reverse transcription and amplification of a genomic segment, transitioning double-stranded DNA into its GQ conformation through a pH-mediated process.
What is HIV
- HIV stands for Human Immunodeficiency Virus, which is a virus that attacks the immune system in the human body.
- It primarily targets and damages CD4 immune cells (a type of White Blood Cell), which are essential for the body’s ability to fight infections and diseases.
- Over time, HIV weakens the immune system, leaving the body vulnerable to opportunistic infections and cancers.
Transmission
- HIV is primarily spread through the exchange of certain bodily fluids such as blood, semen, vaginal fluids, and breast milk.
Severity
- If left untreated, the virus destroys a person’s immune system and they are said to be in the Acquired Immunodeficiency Syndrome stage (AIDS) where they get several opportunistic infections that may result in death.
Cure
- Although there are no cures for the infection at present, the disease can be managed using antiretroviral therapy.
- These medicines suppress the replication of the virus within the body, allowing the number of CD4 immune cells to bounce back.
What is the State of HIV Infection in India
Current Prevalence
- According to the National AIDS Control Organization (NACO), as of 2021, approximately 2.4 million people are living with HIV in India, with an adult prevalence rate of 0.22%.
- The India HIV Estimates 2021 report indicated that there were about 2.3 million people living with HIV, showing a downward trend in new infections
- Demographic Distribution: The epidemic is concentrated among high-risk populations, including female sex workers (2.61%) and injecting drug users ( 5.91%),
- Children under 15 years account for about 3.5% of all infections, while women represent approximately 39% of the total HIV-positive population.
- High-Prevalence States: The northeast region States have the highest adult HIV prevalence (2.70% in Mizoram, 1.36% in Nagaland and 1.05% in Manipur), followed by southern States (0.67% in Andhra Pradesh, 0.47% in Telangana and 0.46% in Karnataka).
- The number of People Living with HIV (PLHIV) is estimated at around 24 lakhs. Southern States have the largest number of PLHIV viz. Maharashtra, Andhra Pradesh and Karnataka are the top three.